CD123-targeted CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123-targeted CAR-T therapy, covering 2023-04-18 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]